Ropivacaine Fresenius Kabi 10 mg/ml inj. opl. epidur. amp. 5 x 20 ml
Active ingredient: Ropivacaine Hydrochloride
View notice details →
News topic
All current shortage notices related to Expected end: 2026-06, structured by product, country, active ingredient and reporting period.
11 noticesActive ingredient: Ropivacaine Hydrochloride
View notice details →Active ingredient: Cloperastine Hydrochloride
View notice details →Active ingredient: Acetylsalicylic Acid
View notice details →Active ingredient: Amlodipine
View notice details →Active ingredient: Losartan Potassium
View notice details →Active ingredient: Caspofungin
View notice details →Active ingredient: Paracetamol; Tramadol Hydrochloride
View notice details →Active ingredient: Quetiapine
View notice details →Active ingredient: Levobupivacaine
View notice details →Active ingredient: Desloratadine
View notice details →Active ingredient: Trifarotene
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →